Dissecting the significance of ACP1 gene alterations in prostate cancer (PCa) | Caris Life Sciences
Home / Research / Publications / Dissecting the significance of ACP1 gene alterations in prostate cancer (PCa)

Publications

Dissecting the significance of ACP1 gene alterations in prostate cancer (PCa)

Abstract

Background:

  • The acid phosphatase 1 (ACP1) gene encodes low molecular weight protein tyrosine phosphatase (LMPTP), which is overexpressed in PCa.
  • Previous studies demonstrate that LMPTP plays a critical role in PCa growth and metastasis and is evolving as a potential therapeutic target.
  • Thus, we analyzedACP1expression in primary and metastatic PCa samples and the association ofACP1with molecular profiles and clinical outcomes.
Download Publication
Learn More
Name(Required)